Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE BUSINESS ROUNDTABLE, INC. · Firm: S-3 GROUP
Issues related to corporate and international tax; H.R.1 One Big Beautiful Bill Act of 2025
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
INTERFOR CORPORATION via S-3 GROUP
2026 · third_quarter · Q3
Issues related to lumber tariffs
Issues related to housing policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| INTERFOR CORPORATION |
| 3 |
| 2026 |
| REPUBLIC SERVICES, INC. | 3 | 2026 |
| ROCKET LIMITED PARTNERSHIP (F/K/A RKT HOLDINGS, LLC) | 3 | 2026 |
| S&P GLOBAL | 3 | 2026 |
| SAZERAC COMPANY, INC. | 3 | 2026 |
| XCEL ENERGY SERVICES, INC. | 3 | 2026 |
| AIR LINE PILOTS ASSOCIATION | 2 | 2026 |
| ALLIANCE OF COMMUNITY HEALTH PLANS | 2 | 2026 |
| BROWN-FORMAN CORPORATION | 2 | 2026 |
| CONOCOPHILLIPS | 2 | 2026 |
| CONSUMER TECHNOLOGY ASSOCIATION | 2 | 2026 |
| DAVITA, INC. | 2 | 2026 |
| GOODRX | 2 | 2026 |
| HUMANA, INC. | 2 | 2026 |
| INTEL CORPORATION | 2 | 2026 |
| JAPAN TOBACCO INTERNATIONAL USA INC. | 2 | 2026 |
| JPMORGAN CHASE HOLDINGS LLC | 2 | 2026 |
| LOWE'S COMPANIES INC | 2 | 2026 |
| LVMH MOET HENNESSY LOUIS VUITTON INC. | 2 | 2026 |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2 | 2026 |
| NOVO NORDISK, INC. | 2 | 2026 |
| OSHKOSH CORPORATION | 2 | 2026 |
| SANDOZ INC. | 2 | 2026 |
| SCHNEIDER ELECTRIC | 2 | 2026 |
| SWISHER INTERNATIONAL INC. | 2 | 2026 |
| THE BOEING COMPANY | 2 | 2026 |
| THE BUSINESS ROUNDTABLE, INC. | 2 | 2026 |
| WALGREEN COMPANY | 2 | 2026 |
| AMERICAN COUNCIL FOR CAPITAL FORMATION | 1 | 2026 |
| AMERICAN INNOVATORS NETWORK | 1 | 2026 |
| COALTION FOR ADULT BEVERAGE ALTERNATIVES | 1 | 2026 |
| SKYDIO, INC. | 1 | 2026 |
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
Issues related to preventing organized retail crime, including the Combatting Organized Retail Crime Act: (H.R. 2853/S.1404)
Issues related to preventing organized retail crime, including the Combatting Organized Retail Crime Act: (H.R. 2853/S.1404)
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
General healthcare policy issues, including Medicare Advantage, Medicare Part D and other payer policy matters, and health care clinical services; S.1105: No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act; PL 119-21: One Big Beautiful Bill Act
General healthcare policy issues, including Medicare Advantage, Medicare Part D and other payer policy matters, and health care clinical services; S.1105: No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act; PL 119-21: One Big Beautiful Bill Act
Issues related to preventing organized retail crime, including the Combatting Organized Retail Crime Act: (H.R. 2853/S.1404)
Issues related to preventing organized retail crime, including the Combatting Organized Retail Crime Act: (H.R. 2853/S.1404)
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
Farm, Food, and National Security Act of 2024
Client: COALTION FOR ADULT BEVERAGE ALTERNATIVES · Firm: S-3 GROUP
General hemp issues; H.R. 8467 - Family, Food, and National Security Act of 2024
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
2026 · third_quarter · Q3
Commercial issues related to the beverage alcohol industry
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN INNOVATORS NETWORK via S-3 GROUP
2026 · third_quarter · Q3
Issues related to the regulation of artificial intelligence
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK, INC. via S-3 GROUP
2026 · third_quarter · Q3
Issues related to tariffs and importation of counterfeit drugs.
Issues related to drug pricing and implementation of the Inflation Reduction Act; coverage of anti-obesity medications; pharmacy benefit management reforms; Most Favored Nation drug pricing.
Issues related to compounding and counterfeit drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
Issues regarding permitting reform
Issues regarding permitting reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JAPAN TOBACCO INTERNATIONAL USA INC. via S-3 GROUP
2026 · third_quarter · Q3
Monitor trade, tax issues and regulations
Monitor trade, tax issues and regulations
Monitor trade, tax issues and regulations
Monitor trade, tax issues and regulations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BROWN-FORMAN CORPORATION via S-3 GROUP
2026 · third_quarter · Q3
Issues related to corporate tax policy, tariffs, including duty drawbacks
Issues related to proposed FDA dietary guidelines for alcohol
Issues related to corporate tax policy, tariffs, including duty drawbacks
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COUNCIL FOR CAPITAL FORMATION via S-3 GROUP
2026 · third_quarter · Q3
Advocating for the development of a robust steel and aluminum industry
Advocating for the development of a robust steel and aluminum industry
Advocating for the development of a robust steel and aluminum industry
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SWISHER INTERNATIONAL INC. via S-3 GROUP
2026 · third_quarter · Q3
Issues pertaining to tobacco and nicotine; monitoring activity at FDA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding lower prescription drug prices for patients
Issues regarding lower prescription drug prices for patients
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OSHKOSH CORPORATION via S-3 GROUP
2026 · third_quarter · Q3
US manufacturing and international competitiveness
US manufacturing and international competitiveness
US manufacturing and international competitiveness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOM ENERGY CORPORATION via S-3 GROUP
2026 · third_quarter · Q3
Issues related to fuel cell tax credits
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COUNCIL ON FOUNDATIONS INC. via S-3 GROUP
2026 · third_quarter · Q3
Strategies and policy advice on tax policy matters with respect to the philanthropic sector
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC SERVICES, INC. via S-3 GROUP
2026 · third_quarter · Q3
Issues related to waste management, recycling and circularity, environmental policy, and taxation
Issues related to waste management, recycling and circularity, environmental policy, and taxation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
Issues related to dialysis payment policy, including End Stage Renal Disease (ESRD) Perspective Payment System (PPS)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS INSTITUTE OF TECHNOLOGY via S-3 GROUP
2026 · third_quarter · Q3
Issues related to higher education
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LOWE'S COMPANIES INC. via S-3 GROUP
2026 · third_quarter · Q3
Issues related to corporate tax reform
Issues related to corporate tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN COMPANY via S-3 GROUP
2026 · third_quarter · Q3
Issues related to the provider status of pharmacists under Medicare Part B
Issues related to preventing organized retail crime, including the Combatting Organized Retail Crime Act: (H.R. 2853/S.1404)
Issues related to pharmacy, pharmacist provider status, pharmacy benefit managers, Medicare reimbursement, and pharmaceutical supply chain transparency
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FORIS DAX, INC. D/B/A CRYPTO.COM via S-3 GROUP
2026 · third_quarter · 3T
Advocating on behalf of users of cryptocurrency and the process of how consumers invest, save, trade, in the digital place
Advocating on behalf of users of cryptocurrency and the process of how consumers invest, save, trade, in the digital place
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTEL CORPORATION via S-3 GROUP
2026 · third_quarter · Q3
Issues related to trade and tariffs
Issues related to support for domestic chipmakers in NDAA
Issues related to Inter Partes Review and patent litigation at the ITC
COALTION FOR ADULT BEVERAGE ALTERNATIVES via S-3 GROUP
2026 · third_quarter · Q3
FY2026 Appropriations
General hemp issues; H.R. 8467 - Family, Food, and National Security Act of 2024
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCKET LIMITED PARTNERSHIP F/K/A RKT HOLDINGS, LLC via S-3 GROUP
2026 · third_quarter · Q3
Mortgage servicing and data privacy issues; general FHA, FHFA, VA, USDA issues; oversight of federal housing policy
General tax reform; qualified office conversion tax credit
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to tax filing
Issues related to tax filing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANDOZ INC. via S-3 GROUP
2026 · third_quarter · Q3
Issues and legislative proposals on biosimilars and generics medicines, including but not limited to generics and biosimilar sustainability, pharmaceutical supply chain security, drug shortages, interchangeability, patent litigation, and PBM reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR LINE PILOTS ASSOCIATION via S-3 GROUP
2026 · third_quarter · Q3
Issues specific to aviation and pilots
General aviation issues
Aviation safety; single pilot operations
SCHNEIDER ELECTRIC via S-3 GROUP
2026 · third_quarter · Q3
Electrification policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER TECHNOLOGY ASSOCIATION via S-3 GROUP
2026 · third_quarter · Q3
General educational meetings on policy issues impacting tech platforms
Monitor issues related to consumer data privacy, and children's privacy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via S-3 GROUP
2026 · third_quarter · Q3
Issues related to healthcare; Medicare Advantage and Medicaid
Issues related to healthcare; Medicare Advantage and Medicaid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BUSINESS ROUNDTABLE, INC. via S-3 GROUP
2026 · third_quarter · Q3
Issues related to trade and tariff policy; issues relating to Russia sanctions
Tax, trade, economic issues, and government funding
Issues relating to artificial intelligence
2026 · third_quarter · Q3
General healthcare policy issues, including Medicare Advantage, Medicare Part D and other payer policy matters, and health care clinical services; S.1105: No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act; PL 119-21: One Big Beautiful Bill Act
Issued related to PL 119-21: One Big Beautiful Bill Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FORIS DAX, INC. D/B/A CRYPTO.COM via S-3 GROUP
2026 · third_quarter · Q3
Advocating on behalf of users of cryptocurrency and the process of how consumers invest, save, trade, in the digital place
Advocating on behalf of users of cryptocurrency and the process of how consumers invest, save, trade, in the digital place
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAZERAC COMPANY, INC. via S-3 GROUP
2026 · third_quarter · Q3
Proposed tariffs and impact on exports and imports of distilled spirits.
Food and beverage policy issues, including U.S. dietary guidelines; support appropriations or U.S. Alcohol and Tobacco Tax and Trade Bureau; issues pertaining to the alcohol industry.
Issues related to duty drawback and alcohol taxes.
AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. via S-3 GROUP
2026 · third_quarter · Q3
Issues related to Rx drug pricing
Issues related to health care research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LVMH MOET HENNESSY LOUIS VUITTON INC. via S-3 GROUP
2026 · third_quarter · Q3
Federal policy relating to general tax policy, trade agreements, consumer protection, and general regulatory matters impacting the fashion, wines and spirits, perfume and cosmetic, watch and jewelry, and related luxury products industry
Federal policy relating to general tax policy, trade agreements, consumer protection, and general regulatory matters impacting the fashion, wines and spirits, perfume and cosmetic, watch and jewelry, and related luxury products industry
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
JPMORGAN CHASE HOLDINGS LLC via S-3 GROUP
2026 · third_quarter · Q3
Issues related to banking and financial services and Financial Services Appropriations
Issues related to the budget and the implementation of financial services legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
XCEL ENERGY SERVICES, INC. via S-3 GROUP
2026 · third_quarter · Q3
Electric and gas utility issues under the tax code and the Federal Power Act, including issues related to renewables
Electric and gas utility issues under the tax code and the Federal Power Act, including issues related to renewables
Electric and gas utility issues under the tax code and the Federal Power Act, including issues related to renewables
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S&P GLOBAL via S-3 GROUP
2026 · third_quarter · Q3
Issues related to infrastructure
Issues related to credit rating agencies and commodity/ financial derivatives and benchmarks; privacy issues
Issues related to the pricing of aluminum
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BOEING COMPANY via S-3 GROUP
2026 · third_quarter · Q3
Issues addressed in FY27 Appropriations / NDAA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · fourth_quarter · RR
Issues related to U.S. manufacturing and use of unmanned aircraft systems, including appropriations and legislation affecting public safety, homeland security, and national security.
Issues related to U.S. manufacturing and use of unmanned aircraft systems, including appropriations and legislation affecting public safety, homeland security, and national security.
Issues related to U.S. manufacturing and use of unmanned aircraft systems, including appropriations and legislation affecting public safety, homeland security, and national security.
INTERFOR CORPORATION via S-3 GROUP
2026 · second_quarter · Q2
Issues related to lumber tariffs
Issues related to housing policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERFOR CORPORATION via S-3 GROUP
2026 · second_quarter · RR
Issues related to lumber tariffs and US housing policy
Issues related to lumber tariffs and US housing policy
CONSTELLATION BRANDS via S-3 GROUP
2026 · second_quarter · Q2
Commercial issues related to the beverage alcohol industry
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK, INC. via S-3 GROUP
2026 · second_quarter · Q2
Issues related to tariffs and importation of counterfeit drugs.
Issues related to compounding and counterfeit drugs.
Issues related to drug pricing and implementation of the Inflation Reduction Act; coverage of anti-obesity medications; pharmacy benefit management reforms; Most Favored Nation drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
Issues regarding permitting reform
Issues regarding permitting reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JAPAN TOBACCO INTERNATIONAL USA INC. via S-3 GROUP
2026 · second_quarter · Q2
Monitor trade, tax issues and regulations
Monitor trade, tax issues and regulations
Monitor trade, tax issues and regulations
BROWN-FORMAN CORPORATION via S-3 GROUP
2026 · second_quarter · Q2
Issues related to proposed FDA dietary guidelines for alcohol
Issues related to corporate tax policy, tariffs, including duty drawbacks
Issues related to corporate tax policy, tariffs, including duty drawbacks
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SWISHER INTERNATIONAL INC. via S-3 GROUP
2026 · second_quarter · Q2
Issues pertaining to tobacco and nicotine; monitoring activity at FDA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding lower prescription drug prices for patients
Issues regarding lower prescription drug prices for patients
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OSHKOSH CORPORATION via S-3 GROUP
2026 · second_quarter · Q2
US manufacturing and international competitiveness
US manufacturing and international competitiveness
US manufacturing and international competitiveness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOM ENERGY CORPORATION via S-3 GROUP
2026 · second_quarter · Q2
Issues related to fuel cell tax credits
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COUNCIL ON FOUNDATIONS INC. via S-3 GROUP
2026 · second_quarter · Q2
Strategies and policy advice on tax policy matters with respect to the philanthropic sector
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC SERVICES, INC. via S-3 GROUP
2026 · second_quarter · Q2
Issues related to waste management, recycling and circularity, environmental policy, and taxation
Issues related to waste management, recycling and circularity, environmental policy, and taxation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
Issues related to dialysis payment policy, including End Stage Renal Disease (ESRD) Perspective Payment System (PPS)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS INSTITUTE OF TECHNOLOGY via S-3 GROUP
2026 · second_quarter · Q2
Issues related to higher education
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LOWE'S COMPANIES INC. via S-3 GROUP
2026 · second_quarter · Q2
Issues related to corporate tax reform
Issues related to corporate tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN COMPANY via S-3 GROUP
2026 · second_quarter · Q2
Issues related to preventing organized retail crime, including the Combatting Organized Retail Crime Act: (H.R. 2853/S.1404)
Issues related to the provider status of pharmacists under Medicare Part B
Issues related to pharmacy, pharmacist provider status, pharmacy benefit managers, Medicare reimbursement, and pharmaceutical supply chain transparency
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTEL CORPORATION via S-3 GROUP
2026 · second_quarter · Q2
Issues related to support for domestic chipmakers in NDAA
Issues related to semiconductor competitiveness
Issues related to trade and tariffs
ROCKET LIMITED PARTNERSHIP F/K/A RKT HOLDINGS, LLC via S-3 GROUP
2026 · second_quarter · Q2
General tax reform; qualified office conversion tax credit
Mortgage servicing and data privacy issues; general FHA, FHFA, VA, USDA issues; oversight of federal housing policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to tax filing
Issues related to tax filing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANDOZ INC. via S-3 GROUP
2026 · second_quarter · Q2
Issues and legislative proposals on biosimilars and generics medicines, including but not limited to generics and biosimilar sustainability, pharmaceutical supply chain security, drug shortages, interchangeability, patent litigation, and PBM reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR LINE PILOTS ASSOCIATION via S-3 GROUP
2026 · second_quarter · Q2
General aviation issues
General aviation issues
Issues specific to aviation and pilots
SCHNEIDER ELECTRIC via S-3 GROUP
2026 · second_quarter · Q2
Electrification policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER TECHNOLOGY ASSOCIATION via S-3 GROUP
2026 · second_quarter · Q2
Monitor issues related to consumer data privacy, and children's privacy
General educational meetings on policy issues impacting tech platforms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via S-3 GROUP
2026 · second_quarter · Q2
Issues related to healthcare; Medicare Advantage and Medicaid
Issues related to healthcare; Medicare Advantage and Medicaid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BUSINESS ROUNDTABLE, INC. via S-3 GROUP
2026 · second_quarter · Q2
Privacy issues
Issues related to corporate and international tax; H.R.1 One Big Beautiful Bill Act of 2025
Tax, trade, economic issues, and government funding
2026 · second_quarter · Q2
General healthcare policy issues, including Medicare Advantage, Medicare Part D and other payer policy matters, and health care clinical services; S.1105: No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act; PL 119-21: One Big Beautiful Bill Act
Issued related to PL 119-21: One Big Beautiful Bill Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FORIS DAX, INC. D/B/A CRYPTO.COM via S-3 GROUP
2026 · second_quarter · Q2
Advocating on behalf of users of cryptocurrency and the process of how consumers invest, save, trade, in the digital place
Advocating on behalf of users of cryptocurrency and the process of how consumers invest, save, trade, in the digital place
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAZERAC COMPANY, INC. via S-3 GROUP
2026 · second_quarter · Q2
Issues relating to counterfeit and illegal sales of alcoholic beverages
Issues related to duty drawback and alcohol taxes.
Food and beverage policy issues, including U.S. dietary guidelines; support appropriations or U.S. Alcohol and Tobacco Tax and Trade Bureau; issues pertaining to the alcohol industry.
AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. via S-3 GROUP
2026 · second_quarter · Q2
Issues related to health care research
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LVMH MOET HENNESSY LOUIS VUITTON INC. via S-3 GROUP
2026 · second_quarter · Q2
Federal policy relating to general tax policy, trade agreements, consumer protection, and general regulatory matters impacting the fashion, wines and spirits, perfume and cosmetic, watch and jewelry, and related luxury products industry
Federal policy relating to general tax policy, trade agreements, consumer protection, and general regulatory matters impacting the fashion, wines and spirits, perfume and cosmetic, watch and jewelry, and related luxury products industry
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
JPMORGAN CHASE HOLDINGS LLC via S-3 GROUP
2026 · second_quarter · Q2
Issues related to the budget and the implementation of financial services legislation
Issues related to banking and financial services and Financial Services Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
XCEL ENERGY SERVICES, INC. via S-3 GROUP
2026 · second_quarter · Q2
Electric and gas utility issues under the tax code and the Federal Power Act, including issues related to renewables
Electric and gas utility issues under the tax code and the Federal Power Act, including issues related to renewables
Electric and gas utility issues under the tax code and the Federal Power Act, including issues related to renewables
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S&P GLOBAL via S-3 GROUP
2026 · second_quarter · Q2
Issues related to the pricing of aluminum
Issues related to credit rating agencies and commodity/ financial derivatives and benchmarks; privacy issues
Issues related to infrastructure
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BOEING COMPANY via S-3 GROUP
2026 · second_quarter · Q2
Issues addressed in FY27 Appropriations / NDAA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSTELLATION BRANDS via S-3 GROUP
2026 · second_quarter · RR
Commercial issues related to the beverage alcohol industry
BLOOM ENERGY CORPORATION via S-3 GROUP
2026 · first_quarter · Q1
Issues related to fuel cell tax credits
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COUNCIL ON FOUNDATIONS INC. via S-3 GROUP
2026 · first_quarter · Q1
Strategies and policy advice on tax policy matters with respect to the philanthropic sector
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC SERVICES, INC. via S-3 GROUP
2026 · first_quarter · Q1
Issues related to waste management, recycling and circularity, environmental policy, and taxation
Issues related to waste management, recycling and circularity, environmental policy, and taxation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCKET LIMITED PARTNERSHIP F/K/A RKT HOLDINGS, LLC via S-3 GROUP
2026 · first_quarter · Q1
Mortgage servicing and data privacy issues; general FHA, FHFA, VA, USDA issues; oversight of federal housing policy
General tax reform; qualified office conversion tax credit
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to tax filing
Issues related to tax filing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAZERAC COMPANY, INC. via S-3 GROUP
2026 · first_quarter · Q1
Proposed tariffs and impact on exports and imports of distilled spirits.
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
Issues related to duty drawback and alcohol taxes.
AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. via S-3 GROUP
2026 · first_quarter · Q1
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Issues related to health care research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
XCEL ENERGY SERVICES, INC. via S-3 GROUP
2026 · first_quarter · Q1
Electric and gas utility issues under the tax code and the Federal Power Act, including issues related to renewables
Electric and gas utility issues under the tax code and the Federal Power Act, including issues related to renewables
Electric and gas utility issues under the tax code and the Federal Power Act, including issues related to renewables
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S&P GLOBAL via S-3 GROUP
2026 · first_quarter · Q1
Issues related to the pricing of aluminum
Issues related to infrastructure
Issues related to credit rating agencies and commodity/ financial derivatives and benchmarks; privacy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to R&D tax credit
Issues related to funding for CHIPS Act
Issues related to semiconductor competitiveness
Issues in support for STEM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General aviation issues
Issues relating to No Tax On Overtime provision
Issues involving mandatory retirement age for pilots
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to corporate and international tax
Issues relating to capital allocation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
Issues relating to counterfeit and illegal sales of alcoholic beverages
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to U.S. manufacturing and use of unmanned aircraft systems, including appropriations and legislation affecting public safety, homeland security, and national security.
Monitor trade, tax issues and regulations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to funding for CHIPS Act
Issues related to R&D tax credit
Issues in support for STEM
Issues related to Inter Partes Review and patent litigation at the ITC
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to No Tax On Overtime provision
Aviation safety; single pilot operations
Issues involving mandatory retirement age for pilots
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to artificial intelligence
Issues related to trade and tariff policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Proposed tariffs and impact on exports and imports of distilled spirits.
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to counterfeit and illegal sales of alcoholic beverages
Food and beverage policy issues, including U.S. dietary guidelines; support appropriations or U.S. Alcohol and Tobacco Tax and Trade Bureau; issues pertaining to the alcohol industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE